Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys.

Human molecular genetics - 29 Aug 2020

Dang Utkarsh J, Ziemba Michael, Clemens Paula R, Hathout Yetrib, Conklin Laurie S, Hoffman Eric P

Abstract excerpt

Duchenne muscular dystrophy (DMD) is caused by loss of dystrophin in muscle, and while all patients share the primary gene and biochemical defect, there is considerable patient-patient variability in clinical symptoms. We sought to develop multivariate models of serum protein biomarkers that explained observed variation, using functional outcome measures as proxies for severity. Serum samples from 39...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Child
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dystrophin

Share to Muscular Dystrophy, Duchenne

Share to Oligonucleotides

Share to Severity of Illness Index

Share to Steroids

Source

Open in PubMed Open full text

Identifiers

PMID: 32592467
DOI: 10.1093/hmg/ddaa132
PMCID: PMC7471506

Genes

DMD
CNTF
ERBB4
SOD1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys.PMID 32592467Read ↗

A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)Semantic proximity Read ↗

Large-scale Proteomics Profiling of Peripheral Blood of DM1 patients identifies biomarkers for disease severity and functional capacitySemantic proximity Read ↗

Combined use of protein biomarkers and network analysis unveils deregulated regulatory circuits in Duchenne muscular dystrophySemantic proximity Read ↗

Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive ReviewSemantic proximity Read ↗

Differentiation of Pediatric-Onset Duchenne and Becker Muscular Dystrophy Subphenotypes Using Data from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet).Semantic proximity Read ↗

Contrasting Becker and Duchenne muscular dystrophy serum biomarker candidates by using data independent acquisition LC-MS/MSSemantic proximity Read ↗

Is it time for genetic modifiers to predict prognosis in Duchenne muscular dystrophy?Semantic proximity Read ↗

Large-scale serum protein biomarker discovery in Duchenne muscular dystrophySemantic proximity Read ↗

Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy.Semantic proximity Read ↗

Circulating Biomarkers for Duchenne Muscular DystrophySemantic proximity Read ↗

Duchenne Muscular Dystrophy: recent advances in protein biomarkers and the clinical applicationSemantic proximity Read ↗

The “Usual Suspects”: Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular DystrophySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.